Bulletin
Investor Alert

Retrophin Inc.

NAS: RTRX

GO
/marketstate/country/us

After Hours

/zigman2/quotes/204610782/composite

$

17.28

Change

0.00 0.00%

Volume

Volume 2,807

Feb 21, 2020, 4:01 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/204610782/composite

Previous close

$ 17.18

$ 17.28

Change

+0.10 +0.58%

Day low

Day high

$16.98

$17.40

Open
Open: 17.13

52 week low

52 week high

$10.87

$24.69

Open

Market cap

$742.31M

Average volume

367,703

P/E ratio

N/A

Rev. per Employee

$767,505

EPS

-2.94

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/rtrx

MarketWatch News on RTRX

  1. Retrophin stock price target cut to $35 from $40 at SVB Leerink

    1:54 p.m. Aug. 22, 2019

    - Tomi Kilgore

  2. Retrophin started at buy with $57 stock price target at Instinet

    8:44 a.m. Nov. 19, 2018

    - Tomi Kilgore

  3. Martin Shkreli’s ex-lawyer found guilty of aiding fraud scheme

    6:36 p.m. Dec. 27, 2017

    - Rebecca Davis O’Brien

  4. Martin Shkreli’s criminal trial begins today

    10:12 a.m. June 26, 2017

    - Emma Court

  5. Pharma M&A Is on the Way

    2:47 a.m. Nov. 12, 2016

    - Barron's Online

  6. Dow Climbs 5.4% on the Heels of Trump’s Victory

    8:34 p.m. Nov. 13, 2016

    - Barron's Online

  7. Biotech Stocks: Look At Those Takeover Premiums!

    12:53 p.m. Sept. 1, 2016

    - Barrons Blogs

  8. Martin Shkreli hit with new securities charge: report

    5:55 p.m. June 3, 2016

    - Wallace Witkowski

  9. Even more charges are probably coming Martin Shkreli’s way

    11:41 a.m. May 3, 2016

    - Christopher M. Matthews

  10. Martin Shkreli hired same audit firm for KaloBios used at Retrophin

    8:19 a.m. Dec. 29, 2015

    - Francine McKenna

  11. Martin Shkreli terminated as KaloBios CEO

    10:49 a.m. Dec. 21, 2015

    - Lisa Beilfuss

  12. Last Week

    2:46 a.m. Dec. 19, 2015

    - Barron's Online

  13. The Big Short Falls Short

    11:43 a.m. March 14, 2016

    - Barron's Online

  14. These are the charges against Martin Shkreli

    12:55 p.m. Dec. 17, 2015

    - MarketWatch

  15. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/rtrx

Other News on RTRX

  1. Retrophin provides corporate update and 2020 outlook

    9:48 a.m. Jan. 13, 2020

    - Seeking Alpha

  2. 5 Beaten-Down Biotech Stocks Set to Rebound in 2020

    7:59 a.m. Dec. 18, 2019

    - Zacks.com

  3. Martin Shkreli’s Appeal Is Rebuffed by Supreme Court

    7:19 p.m. Nov. 18, 2019

    - The Wall Street Journal Interactive Edition

  4. Top Ranked Momentum Stocks to Buy for November 7th

    10:21 a.m. Nov. 7, 2019

    - Zacks.com

  5. Retrophin Q3 2019 Earnings Preview

    4:35 p.m. Oct. 29, 2019

    - Seeking Alpha

  6. Retrophin: Thesis Falls Back To Sparsentan

    10:23 p.m. Oct. 14, 2019

    - Seeking Alpha

  7. Retrophin (RTRX) Investor Presentation - Slideshow

    4:33 p.m. Oct. 3, 2019

    - Seeking Alpha

  8. BioMarin readies study of gene therapy for PKU

    9:14 a.m. Sept. 26, 2019

    - Seeking Alpha

  9. BJ, FLWS, JWN, PSTG, SPLK and YJ among midday movers

    11:40 a.m. Aug. 22, 2019

    - Seeking Alpha

  10. Loading more headlines...
/news/pressrelease/company/us/rtrx

Press Releases on RTRX

  1. Retrophin to Present at Upcoming Investor Conferences

    4:30 p.m. Feb. 19, 2020

    - GlobeNewswire

  2. Retrophin to Present at Upcoming Investor Conferences

    4:30 p.m. Feb. 19, 2020

    - GlobeNewswire

  3. Melanocortin Receptor 4 Market Update - Rising Cash Flows is King

    11:55 a.m. Jan. 30, 2020

    - HTF Market Intelligence

  4. Retrophin Provides Corporate Update and 2020 Outlook

    6:59 a.m. Jan. 13, 2020

    - GlobeNewswire

  5. Retrophin Provides Corporate Update and 2020 Outlook

    6:59 a.m. Jan. 13, 2020

    - GlobeNewswire

  6. Loading more headlines...

Rates »

Link to MarketWatch's Slice.